Biotechnology Get all the latest news from the field of biotechnology and its many applications, including testing, treatment, and pharmaceuticals. This category includes research, clinical, and study results, as well as stories about the newest breakthroughs in the industry. Read stories about upcoming conferences and symposiums, along with releases regarding patents, legal activity, company performance, and market analysis.

Latest

11:00 ETIMBA - Institut für Molekulare Biotechnologie GmbH: Growing Brain Cancer in a Dish

For the first-time, researchers at IMBA - Institute of Molecular Biotechnology of the Austrian Academy of Sciences - develop organoids, that mimic...


11:00 ETIMBA - Institut für Molekulare Biotechnologie GmbH: Growing Brain Cancer in a Dish

For the first-time, researchers at IMBA - Institute of Molecular Biotechnology of the Austrian Academy of Sciences - develop organoids, that mimic...


11:00 ET"Hijacked" Cell Response to Stress Reveals Promising Drug Targets for Blood Cancer

A signaling pathway that helps promote normal cell growth worsens a form of leukemia by taking control of another pathway better known for protecting ...


10:13 ETPulmatrix Announces the Formation of the Pulmazole Clinical Advisory Board to Support Future Development

Pulmatrix, Inc. (NASDAQ: PULM), a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary...


10:00 ETPeptide Synthesis Market to Grow at 6.5% CAGR to 2023 - ReportsnReports.com

Peptide synthesis market is projected to reach USD 426.4 million by 2023 from USD 310.5 million in 2018, at a CAGR of 6.5%. The peptide synthesis...


10:00 ETPeptide Synthesis Market to Grow at 6.5% CAGR to 2023 - ReportsnReports.com

Peptide synthesis market is projected to reach USD 426.4 million by 2023 from USD 310.5 million in 2018, at a CAGR of 6.5%. The peptide synthesis...


09:44 ETBiotech Companies Investing Millions of Dollars in the Medical Marijuana Market to Develop Cannabinoid Products

Frost & Sullivan's recent analysis on medical cannabis finds that the total revenue of this market in the United States is expected to grow from...


09:42 ETEspecialista em ciência de dados Nuria Oliver se une ao conselho consultivo da Comviva

A Comviva, líder global de soluções de mobilidade, tem o prazer de anunciar que Nuria Oliver se uniu ao seu conselho consultivo. Nuria é a diretora...


09:38 ETNuria Oliver, experta en Ciencias de Datos, se une a la junta de asesores de Comviva

Comviva, líder global en soluciones de movilidad, se complace en anunciar que Nuria Oliver se ha unido a su junta de asesores. Nuria es Directora de...


09:30 ETBiotech Companies Investing Millions of Dollars in the Medical Marijuana Market to Develop Cannabinoid Products

Frost & Sullivan's recent analysis on medical cannabis finds that the total revenue of this market in the United States is expected to grow from...


09:02 ETSecond Genome Appoints Anupama S. Hoey as Chief Business Officer

Second Genome, Inc., a leader in the development of novel therapeutics derived from the human microbiome, today announced the appointment of Anupama...


08:30 ETCytRx Corporation Announces Expiration of Outstanding Warrants

CytRx Corporation (Nasdaq: CYTR), a biopharmaceutical research and development company specializing in oncology, today announced the expiration of...


08:05 ETBiocept and UC San Diego Moores Cancer Center Announce Collaboration to Study Feasibility of Liquid Biopsy to Predict Disease Recurrence in Solid Tumors and Response to Therapy

Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable...


08:01 ETDermtreat Announces First Patient Dosed in Phase 2b Clinical Trial of Rivelin Clobetasol for Oral Lichen Planus

Dermtreat, a clinical-stage biopharmaceutical company focused on mucosal diseases, today announced treatment of the first patient in a Phase 2b...


08:01 ETAlkahest to Present at Alzheimer's Association International Conference (AAIC) Annual Meeting July 22-26, 2018 Chicago, IL

Alkahest Inc. ("Alkahest"), a clinical-stage biotechnology company focused on developing innovative therapies to treat Alzheimer's Disease and other...


08:00 ETBrainStorm Announces Financial Results for the Second Quarter of 2018 and Provides a Corporate Update

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced today ...


08:00 ETTolero Pharmaceuticals Advances Investigational Agent Alvocidib into Second Stage of Phase 2 Zella 201 Study in Patients with Relapsed Refractory MCL-1-Dependent AML

Tolero Pharmaceuticals, Inc., a clinical-stage company focused on developing novel therapeutics for hematological and oncological diseases, today...


07:00 ETDisarm Therapeutics Presents Data Demonstrating the Protective Effect of SARM1 Deletion on Axonal Degeneration

Disarm Therapeutics, a biotechnology company creating a new class of disease-modifying therapeutics for patients with axonal degeneration, a central...


06:45 ETResearchers Are One Step Closer to Developing Eye Drops to Treat Age-related Macular Degeneration (AMD)

Scientists at the University of Birmingham, UK, are one step closer to developing an eye drop that could revolutionise treatment for age-related...


06:15 ETPre-Market Research Reports on Generic Drugs Stocks -- Tricida, Zoetis, Adamas Pharma, and Allergan

If you want a free Stock Review on TCDA, ZTS, ADMS, and AGN sign up now at https://stocktraderreport.com/registration/. On Friday, key US indices...


05:00 ETOrthoSpin Ltd. Completes $3 Million Raise for Orthopedic Robotic External Fixation System

OrthoSpin Ltd. ("OrthoSpin"), a portfolio company of The Trendlines Group Ltd. ("Trendlines") (SGX: 42T) (OTCQX: TRNLY), announced that it completed...


03:00 ETGrow Biotech PLC's Private Placement Raises £2 Million; Board Targets a Q4 2019 IPO

Grow Biotech PLC ("Grow Biotech", the "Company"), the UK-based medical cannabis biotechnology and intellectual property company, today announces...


02:37 ETNo Toxicity Seen in Mice as Regen BioPharma, Inc. Finishes Initial Optimization of its Lead NR2F6 Small Molecule Agonist

Regen BioPharma Inc.'s (OTCQB: RGBP) and (OTCQB: RGBPP) lead candidate drug, RG-NAE005, was tested for its maximum tolerated dose in mice and showed...


02:30 ETSangamo Therapeutics to Acquire TxCell

Sangamo Therapeutics, Inc. (Nasdaq: SGMO) and TxCell S.A. (ENXTPA: TXCL) announced today that they have entered into a definitive agreement on July...